News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
797,631 Results
Type
Article (61382)
Company Profile (363)
Press Release (735866)
Multimedia
Podcasts (148)
Webinars (22)
Section
Business (218550)
Career Advice (2641)
Deals (37857)
Drug Delivery (159)
Drug Development (86831)
Employer Resources (181)
FDA (17834)
Job Trends (16320)
News (371809)
Policy (36310)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2975)
Accelerated approval (46)
Adcomms (35)
Allergies (176)
Alliances (53701)
ALS (209)
Alzheimer's disease (1868)
Antibody-drug conjugate (ADC) (424)
Approvals (18115)
Artificial intelligence (682)
Autoimmune disease (257)
Automation (55)
Bankruptcy (383)
Best Places to Work (12374)
BIOSECURE Act (21)
Biosimilars (218)
Biotechnology (234)
Bladder cancer (186)
Brain cancer (75)
Breast cancer (730)
Cancer (5715)
Cardiovascular disease (492)
Career advice (2237)
Career pathing (47)
CAR-T (327)
CDC (66)
Celiac Disease (2)
Cell therapy (871)
Cervical cancer (45)
Clinical research (74367)
Collaboration (2105)
Company closure (5)
Compensation (1321)
Complete response letters (91)
COVID-19 (2976)
CRISPR (109)
C-suite (1082)
Cystic fibrosis (160)
Data (7373)
Decentralized trials (3)
Denatured (54)
Depression (175)
Dermatology (70)
Diabetes (584)
Diagnostics (7269)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (329)
Drug pricing (227)
Drug shortages (37)
Duchenne muscular dystrophy (279)
Earnings (94685)
Editorial (71)
Employer branding (22)
Employer resources (160)
Events (127449)
Executive appointments (1107)
FDA (21470)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1759)
Gene editing (234)
Generative AI (66)
Gene therapy (725)
GLP-1 (1164)
Government (5226)
Grass and pollen (8)
Guidances (404)
Healthcare (20638)
HIV (80)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (317)
Immuno-oncology (94)
Indications (164)
Infectious disease (3325)
Inflammatory bowel disease (221)
Inflation Reduction Act (15)
Influenza (138)
Intellectual property (282)
Interviews (446)
IPO (17506)
IRA (55)
Job creations (4276)
Job search strategy (1863)
JPM (67)
Kidney cancer (20)
Labor market (95)
Layoffs (624)
Leadership (44)
Legal (8896)
Liver cancer (105)
Longevity (31)
Lung cancer (765)
Lymphoma (421)
Machine learning (56)
Management (62)
Manufacturing (1015)
MASH (191)
Medical device (15061)
Medtech (15148)
Mergers & acquisitions (21545)
Metabolic disorders (1557)
mRNA (209)
Multiple sclerosis (184)
NASH (22)
Neurodegenerative disease (427)
Neuropsychiatric disorders (113)
Neuroscience (3399)
Neurotech (1)
NextGen: Class of 2026 (7279)
Non-profit (5002)
Now hiring (74)
Obesity (756)
Opinion (346)
Ovarian cancer (201)
Pain (252)
Pancreatic cancer (276)
Parkinson's disease (368)
Partnered (34)
Patents (581)
Patient recruitment (645)
Peanut (65)
People (63752)
Pharmaceutical (79)
Pharmacy benefit managers (36)
Phase 1 (23090)
Phase 2 (32611)
Phase 3 (24416)
Pipeline (7607)
Policy (350)
Postmarket research (2928)
Preclinical (9986)
Press Release (71)
Prostate cancer (293)
Psychedelics (56)
Radiopharmaceuticals (339)
Rare diseases (1118)
Real estate (6636)
Recruiting (73)
Regulatory (27527)
Reports (58)
Research institute (2692)
Resumes & cover letters (425)
Rett syndrome (34)
RNA editing (21)
RSV (95)
Schizophrenia (179)
Series A (296)
Series B (219)
Service/supplier (13)
Sickle cell disease (111)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (48)
Startups (4150)
State (2)
Stomach cancer (21)
Supply chain (133)
Tariffs (97)
The Weekly (92)
Vaccines (1202)
Venture capital (107)
Weight loss (510)
Women's health (118)
Worklife (23)
Date
Today (168)
Last 7 days (601)
Last 30 days (2739)
Last 365 days (31662)
2026 (9366)
2025 (31753)
2024 (36965)
2023 (41964)
2022 (53282)
2021 (58053)
2020 (56921)
2019 (50272)
2018 (38180)
2017 (35170)
2016 (35387)
2015 (41307)
2014 (35133)
2013 (30601)
2012 (32786)
2011 (33408)
2010 (32057)
Location
Africa (950)
Alabama (93)
Alaska (7)
Arizona (354)
Arkansas (16)
Asia (45353)
Australia (7612)
California (12731)
Canada (3622)
China (1338)
Colorado (554)
Connecticut (564)
Delaware (388)
Europe (101058)
Florida (1910)
Georgia (423)
Hawaii (3)
Idaho (67)
Illinois (1065)
India (89)
Indiana (588)
Iowa (23)
Japan (518)
Kansas (135)
Kentucky (49)
Louisiana (41)
Maine (75)
Maryland (1574)
Massachusetts (9271)
Michigan (363)
Minnesota (721)
Mississippi (7)
Missouri (155)
Montana (37)
Nebraska (29)
Nevada (143)
New Hampshire (90)
New Jersey (3418)
New Mexico (31)
New York (3395)
North Carolina (1700)
North Dakota (10)
Northern California (6281)
Ohio (385)
Oklahoma (26)
Oregon (46)
Pennsylvania (2572)
Puerto Rico (29)
Rhode Island (52)
South America (1338)
South Carolina (83)
South Dakota (2)
Southern California (5005)
Tennessee (205)
Texas (2036)
United States (45708)
Utah (382)
Vermont (1)
Virginia (311)
Washington D.C. (84)
Washington State (1050)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
797,631 Results for "ra medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance III, could target companies abroad, including those from China.
March 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
March 18, 2026
·
13 min read
Press Releases
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
March 10, 2026
·
7 min read
Press Releases
Equillium Announces $35 Million Financing with RA Capital Management
March 13, 2026
·
5 min read
Press Releases
Landmark RESET-RA Study Published in Nature Medicine Demonstrates Durable Efficacy and Safety of the SetPoint System for Rheumatoid Arthritis
January 5, 2026
·
4 min read
Press Releases
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
March 9, 2026
·
7 min read
Press Releases
Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer
March 20, 2026
·
3 min read
Press Releases
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
March 24, 2026
·
6 min read
Press Releases
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
February 12, 2026
·
4 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
April 6, 2026
·
1 min read
1 of 79,764
Next
